Our findings indicate that the downregulation of NFE2L1 facilitates a transition of TAMs from the M2 phenotype to the M1 phenotype, which in turn hinders the aggressive proliferation of glioma. This evidence concerns the gene NFE2L1 and central nervous system cancer.